Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan.

导出 LinkOut

翻译打印收藏纠错

第一作者： Makoto,Nagata

第一单位： Department of Respiratory Medicine, Saitama Medical University, Saitama, Japan; Allergy Center, Saitama Medical University Hospital, Saitama, Japan. Electronic address: favre4mn@saitama-med.ac.jp.

作者： Makoto,Nagata ^[1] ; Ryo,Yamaguchi ^[2] ; Makiko,Usami ^[2] ; Mami,Orimo ^[2] ; Masato,Ishida ^[2]

作者单位： Department of Respiratory Medicine, Saitama Medical University, Saitama, Japan; Allergy Center, Saitama Medical University Hospital, Saitama, Japan. Electronic address: favre4mn@saitama-med.ac.jp. ^[1] Sanofi K.K., Tokyo, Japan. ^[2]

DOI 10.1016/j.alit.2024.08.003

PMID 39261127

发布时间 2025-01-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Allergology international

2025年74卷1期

169-171页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan.

Allergology international

相似文献

Allergology international

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan.

Allergology international

相似文献

Allergology international

相关期刊

检索历史清除